Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$17.99
1.358.11%
At close: -
$17.99
0.000.00%
After Hours: Jun 20, 4:00 PM EDT
Comments
Loading...
Pharvaris Analyst Ratings and Price Targets | NASDAQ:PHVS | Benzinga
Pharvaris NV has a consensus price target of $34.1 based on the ratings of 10 analysts. The high is $55 issued by Citizens Capital Markets on March 3, 2025. The low is $11 issued by B of A Securities on December 7, 2023. The 3 most-recent analyst ratings were released by Wedbush, Cantor Fitzgerald, and Cantor Fitzgerald on June 5, 2025, May 14, 2025, and April 29, 2025, respectively. With an average price target of $26.67 between Wedbush, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 48.23% upside for Pharvaris NV from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wedbush
Cantor Fitzgerald
Cantor Fitzgerald
Citizens Capital Markets
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Pharvaris
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/05/2025 | Buy Now | 50.08% | Wedbush | Laura Chico51% | $27 → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 05/14/2025 | Buy Now | 38.97% | Cantor Fitzgerald | Timur Ivannikov36% | $28 → $25 | Maintains | Overweight | Get Alert |
| 04/29/2025 | Buy Now | 55.64% | Cantor Fitzgerald | Steven Seedhouse57% | → $28 | Initiates | → Overweight | Get Alert |
| 03/03/2025 | Buy Now | 205.73% | Citizens Capital Markets | Jonathan Wolleben71% | $55 → $55 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/31/2025 | Buy Now | 205.73% | JMP Securities | Jonathan Wolleben71% | $46 → $55 | Maintains | Market Outperform | Get Alert |
| 09/19/2024 | Buy Now | 155.7% | Jones Trading | Debanjana Chatterjee52% | → $46 | Initiates | → Buy | Get Alert |
| 09/06/2024 | Buy Now | 133.46% | Oppenheimer | Justin Kim36% | $38 → $42 | Maintains | Outperform | Get Alert |
| 07/03/2024 | Buy Now | 111.23% | Oppenheimer | Justin Kim36% | $36 → $38 | Maintains | Outperform | Get Alert |
| 05/09/2024 | Buy Now | 72.32% | Wedbush | Laura Chico51% | $35 → $31 | Maintains | Outperform | Get Alert |
| 04/22/2024 | Buy Now | 88.99% | Morgan Stanley | Matthew Harrison61% | $34 → $34 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | 88.99% | Morgan Stanley | Matthew Harrison61% | $35 → $34 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | 94.55% | Wedbush | Laura Chico51% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2024 | Buy Now | 177.93% | JMP Securities | Jonathan Wolleben71% | $49 → $50 | Maintains | Market Outperform | Get Alert |
| 03/19/2024 | Buy Now | 94.55% | Wedbush | Laura Chico51% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 02/14/2024 | Buy Now | 172.37% | JMP Securities | Jonathan Wolleben71% | $49 → $49 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/23/2024 | Buy Now | 172.37% | JMP Securities | Jonathan Wolleben71% | $40 → $49 | Maintains | Market Outperform | Get Alert |
| 12/07/2023 | Buy Now | -38.85% | B of A Securities | Tazeen Ahmad57% | $8 → $11 | Maintains | Underperform | Get Alert |
| 12/07/2023 | Buy Now | 94.55% | Morgan Stanley | Matthew Harrison61% | $32 → $35 | Maintains | Overweight | Get Alert |
| 11/14/2023 | Buy Now | 77.88% | Morgan Stanley | Matthew Harrison61% | $34 → $32 | Maintains | Overweight | Get Alert |
| 11/03/2023 | Buy Now | 33.41% | Wedbush | Laura Chico51% | $27 → $24 | Maintains | Outperform | Get Alert |
| 09/25/2023 | Buy Now | 50.08% | Wedbush | Laura Chico51% | → $27 | Initiates | → Outperform | Get Alert |
| 08/15/2023 | Buy Now | 88.99% | Morgan Stanley | Matthew Harrison61% | $10 → $34 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/01/2023 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/26/2023 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/20/2023 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | → $10 | Reiterates | → Equal-Weight | Get Alert |
| 06/12/2023 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 11.17% | JMP Securities | Jonathan Wolleben71% | → $20 | Reiterates | → Market Outperform | Get Alert |
| 04/06/2023 | Buy Now | 11.17% | JMP Securities | Jonathan Wolleben71% | $23 → $20 | Maintains | Market Outperform | Get Alert |
| 02/27/2023 | Buy Now | 27.85% | JMP Securities | Jonathan Wolleben71% | → $23 | Reiterates | → Market Outperform | Get Alert |
| 02/03/2023 | Buy Now | 0.06% | SVB Leerink | Joseph Schwartz64% | $20 → $18 | Maintains | Outperform | Get Alert |
| 01/11/2023 | Buy Now | 27.85% | JMP Securities | Jonathan Wolleben71% | $22 → $23 | Maintains | Market Outperform | Get Alert |
| 12/09/2022 | Buy Now | 22.29% | JMP Securities | Jonathan Wolleben71% | $18 → $22 | Maintains | Market Outperform | Get Alert |
| 09/14/2022 | Buy Now | 11.17% | SVB Leerink | Joseph Schwartz64% | $25 → $20 | Maintains | Outperform | Get Alert |
| 08/23/2022 | Buy Now | 38.97% | SVB Leerink | Joseph Schwartz64% | $45 → $25 | Maintains | Outperform | Get Alert |
| 08/23/2022 | Buy Now | 22.29% | Oppenheimer | Justin Kim36% | $48 → $22 | Maintains | Outperform | Get Alert |
| 08/23/2022 | Buy Now | -44.41% | Morgan Stanley | Matthew Harrison61% | $40 → $10 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/22/2022 | Buy Now | -27.74% | B of A Securities | Tazeen Ahmad57% | $26 → $13 | Downgrade | Neutral → Underperform | Get Alert |
FAQ
What is the target price for Pharvaris (PHVS) stock?
The latest price target for Pharvaris (NASDAQ:PHVS) was reported by Wedbush on June 5, 2025. The analyst firm set a price target for $27.00 expecting PHVS to rise to within 12 months (a possible 50.08% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pharvaris (PHVS)?
The latest analyst rating for Pharvaris (NASDAQ:PHVS) was provided by Wedbush, and Pharvaris reiterated their outperform rating.
When was the last upgrade for Pharvaris (PHVS)?
The last upgrade for Pharvaris NV happened on August 15, 2023 when Morgan Stanley raised their price target to $34. Morgan Stanley previously had an equal-weight for Pharvaris NV.
When was the last downgrade for Pharvaris (PHVS)?
The last downgrade for Pharvaris NV happened on August 23, 2022 when Morgan Stanley changed their price target from $40 to $10 for Pharvaris NV.
When is the next analyst rating going to be posted or updated for Pharvaris (PHVS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pharvaris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pharvaris was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.
Is the Analyst Rating Pharvaris (PHVS) correct?
While ratings are subjective and will change, the latest Pharvaris (PHVS) rating was a reiterated with a price target of $27.00 to $27.00. The current price Pharvaris (PHVS) is trading at is $17.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
